Zero. That's what has changed.
The legal wrangling is about Cobalis attempting to avoid financial disclosure to Gryphon as required by law.
In the grand scheme of things, they got away with the ploy and it cost the "law firm" (loosely used term) 75K.
As to all those who are long (like I’ve been for nearly 10 yrs), ZERO. I find virtually no credibility in any information put out by the Cobalis reps. The Russian Deal, the Physicians Deal, the Marketing Deal, the Advertising Deal... the Wheel-and-Deal is what is almost always delivered.
Again, I leave open the glimmer of hope... as it appears they are trading again.
I've given up on my investment looooooong ago.... and would like to be WRONG on this one. One day, maybe I’ll get a little UNANTICIPATED return. Until then... I'm off to buy some lottery tickets. (odds of winning the grand prize are 1:7.1mil)
Hey, sorta like my cobalis stock.
Ugot
Oh wait, I'd like to add...I had a sit-down, 2hr conversation w/Chas about 10 years ago. There was no doubt in my mind he believed he could move this co. to the forefront of consumer minds when treating for common pollen-related allergies. Also, he felt Cobalis could be marketed to treat other chronic issues such as migraines.. (of grand interest to me as a migraine sufferer) unfortunately, things don't always turn out the way we plan. Thus, we have the Cobalis of today... a start-up still struggling to find it's legs... and not sure the crutches of business will ever allow that to happen. Greed.. plain and simple.
Good Luck to all.
News 
Market Data 
Discover 
AI
